• If you are wondering whether Aflac's current share price reflects its true worth, the recent performance gives you a useful starting point for a closer look at value.
• The stock last closed at US$112.88, with a 7 day return of a 1.5% decline, a 30 day return of 3.0%, a year to date return of 2.4% and a 1 year return of 9.3%, set against very large gains over 3 and 5 years.
• Recent news coverage has focused on Aflac as a long established insurer with a strong brand and ongoing investor interest rather than short term trading headlines. This steadier news flow gives useful context for assessing whether the current price and recent returns are in line with the underlying business.
• Aflac currently has a valuation score of 3/6, reflecting that it screens as undervalued on half of the checks used. The rest of this article will compare those traditional valuation approaches before finishing with a different way to think about what the stock might be worth.

Approach 1: Aflac Excess Returns Analysis

The Excess Returns model looks at how much profit a company is expected to generate above the return that equity investors require, then converts that stream of excess profit into a per share value today.

For Aflac, the model starts with a Book Value of $57.76 per share and a Stable EPS estimate of $8.29 per share, based on weighted future Return on Equity estimates from 5 analysts. The Average Return on Equity is 13.75%, while the Cost of Equity is $4.21 per share. That leaves an Excess Return of $4.08 per share, which represents the earnings attributed to shareholders above their required return.

The model also uses a Stable Book Value of $60.28 per share, drawn from weighted future Book Value estimates from 8 analysts, to project how these excess returns might compound over time. Bringing all of this together gives an estimated intrinsic value of about $174.66 per share, which implies the stock is 35.4% undervalued relative to the recent share price of US$112.88.

Result: UNDERVALUED

Our Excess Returns analysis suggests Aflac is undervalued by 35.4%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: Aflac Price vs Earnings

For profitable companies, the P/E ratio is a useful way to link what you pay for a share to the earnings that support that price. It helps you judge how many dollars investors are currently willing to pay for each dollar of earnings.

What counts as a "normal" or "fair" P/E depends on how the market views a company’s growth prospects and risk profile. Higher expected growth or lower perceived risk can justify a higher P/E, while lower growth or higher risk usually lines up with a lower multiple.

Aflac currently trades on a P/E of 12.43x. That sits above the Insurance industry average P/E of 11.45x, but below the peer group average of 14.18x. Simply Wall St’s Fair Ratio for Aflac is 9.85x. This Fair Ratio is a proprietary estimate of the P/E that might be reasonable given factors such as Aflac’s earnings growth profile, industry, profit margins, market cap and company specific risks.

Compared with simple peer or industry averages, the Fair Ratio can give a more tailored anchor because it folds in those company specific drivers rather than relying only on broad comparisons. With Aflac’s actual P/E of 12.43x sitting above the Fair Ratio of 9.85x, this indicates that the shares may be trading at a higher valuation on this metric.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Aflac Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so consider Narratives, which are simply your story about Aflac linked to your own assumptions for fair value, future revenue, earnings and margins, and then compared with the current price to help you decide whether the stock looks attractive or expensive at any given time.

On Simply Wall St’s Community page, Narratives give you an accessible way to connect what you believe about Aflac’s business, such as product innovation in Japan, digital initiatives or reliance on that market, to a financial forecast and then to a fair value that updates automatically when new information like earnings, news or analyst targets arrives.

For example, one investor might build an optimistic Aflac Narrative that leans closer to the higher analyst price target of US$126.00 because they put more weight on product launches, digitalization and distribution partnerships. Another might anchor a more cautious Narrative around the lower target of US$97.00 due to concerns about flat revenue, margin pressure or Japan exposure. Each can then compare their own Fair Value with the current price of US$112.88 to decide what action, if any, feels appropriate for their portfolio.

Do you think there's more to the story for Aflac? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.